Vascular Disease Management
INSIGHT INTO DIAGNOSIS AND TREATMENT OF VASCULAR DISEASE
MANAGEMENT
Thursday, May 15, 2008

SEARCH ARTICLES



Home | About
Current Issue
Archives
Subscribe
Board Members
Search Article Archives
Editor's Update
Events & Symposia
Industry News | Enews
Discussion Forum
Classifieds
Letter to the Editor
Comments/Suggestions
Editorial/Production
Author Information
Submit a Manuscript
Review a Manuscript
Order Article Reprints
Advertising
Advertising Specs
Online/Web Production

Featured Article

774
Vascular Disease Management - ISSN: 1553-8036 - Volume 4 - Issue 4 - July 2007
Jinnette Abbott, MD and David Williams, MD
Endovascular specialists are increasingly facing the challenges of treating peripheral arterial chronic total occlusions (CTOs). The two primary issues concerning these lesions are the ability to safely achieve initial angiographic success and the longterm durability of therapy. The advent of new techniques and devices, including re-entry catheters, has increased the crossing success rates for even the most difficult CTOs. Although more effective ways of maintaining vessel patency are needed, nitinol stents have improved immediate outcomes and become the mainstay of therapy. This article will review the percutaneous treatment of peripheral CTOs.
1Robert S. Dieter, MD, RVT, 1Ali Morshedi-Meibodi, MD, 2Aravinda Nanjundappa, MD, RVT

Percutaneous Revascularization of Peripheral Chronic Total Occlusion — Which Patients, Why, and How?
1Aravinda Nanjundappa, MD and 2Robert S. Dieter, MD
Frank J. Criado
Joe Huang, MD, Takao Ohki, MD, PhD

Stent-Graft Placement in Popliteal Artery Aneurysms: Midterm Results
Reza Ghotbi, MD, Agamemnon Sotiriou, MD, Sylvia Schönhofer, MD, Dimitrios Zikos, MD, Kerstin Schips, MD, Wolfgang Westermeier, MD
Purpose. We sought to determine the selection criteria, midterm durability and need for reintervention after stent-graft placement in symptomatic popliteal artery aneurysms (PAA). Methods. Twenty-four patients (22 males and 2 females, mean age 58 years), with a combined 27 aneurysms, underwent an elective stent-graft repair of symptomatic popliteal artery aneurysms between January 1999 and December 2003. When an essential branch would be blocked by an endograft, thrombosed aneurysms and aneurysms were excluded from the study. The commercially available stent-graft Viabahn (W.L. Gore & Associates, Inc., Flagstaff, Arizona) was used in all cases. The primary endpoint was defined as a successful exclusion after a 2-year period. Exclusion success was assessed using duplex ultrasound and spiral computed tomography. Results. The primary technical success rate was 100%. In-hospital mortality was 0%. Two central leaks required reintervention. There were 2 stent-graft occlu

A Single-Center Experience with Simultaneous IVC Filter Placement during Gastric Bypass
1Jeffrey Indes, MD, 1Jeffrey Wang, MD, 2Frank Veith, MD, 1Evan Deutsch, MD, 1Larry Scher, MD

Is Carotid Stenting of Complicated Plaques Safe?
Gianluca Faggioli, MD, Monica Ferri, MD, Mauro Gargiulo, MD, Antonio Freyrie, MD, Francesca Fratesi, MD, 1Lamberto Manzoli, MD, MPH, 2Cristina Rossi, MD, Andrea Stella, MD
Background. Specific plaque characteristics, such as ulcers and subocclusive lesions, may increase the complication rate in carotid stenting (CAS) procedures, however, few data have been published in this regard. Aim. Our goal was to investigate the risk of technical failure and neurological symptoms in complicated and uncomplicated plaques after CAS. Methods. From January 2005 to March 2007, all patients submitted to CAS were divided into two groups depending on plaque morphology: complicated plaque patients (ComP) (plaques with ulcers diameter > 2 mm and plaques determining subocclusive stenosis [i.e., > 99%]); the rest being uncomplicated plaques (UnComP). The two groups were compared in terms of baseline characteristics, preoperative neurological symptoms, cerebral computed tomography, type of arch, presence of stenosis or occlusion of the contralateral carotid, type of stent and protection system, and technical and clinical outcome. Differences across groups in t

VASCULAR TOPICS

Peripheral Angioplasty
Thoracic Stent Grafts
Renal Stenting
Vena Cava Filter
Hemodialysis Management
Computed Tomography
PFO Closure
SFA Stenting
Carotid Stenting
Vessel Closure
Angiography
Carotid Endarterectomy
Ultrasound

Critical Limb Ischemia
Superficial Femoral Artery
Embolization
Device Based Thrombectomy
Pharmacological Management
MRA
Mesenteric Artery Stenting
AAA Stent Grafts
Iliac Stenting
Thrombolysis Procedures Using Drug Therapy

SUPPLEMENTS

Superior Mesenteric Artery Revascularization and Retrograde Visualization
This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.

HMP Increased Cutaneous Sensibility in Patients with Diabetic Neuropathy Utilizing a Pharmacological Approach — Clinical Case Evidence

This clinical case update was supported through an unrestricted educational grant from Pamlab, LLC.

A New Biological Approachto Below-Knee Revascularization
A Review of the GORE PROPATEN Vascular Graft:
The Combination That Lasts

This special supplement was made possible through a grant from W. L. Gore

Combining Bilayered Living Cell Therapy with Minimally Invasive Vein Surgery:
Current Treatment Strategies for Venous Ulcers

This activity is supported by an educational grant from Organogenesis.

Pharmacotherapy in Peripheral Vascular Disease

Platelet Inhibition in Critical Limb Ischemia and Peripheral Vascular Interventions
DAVID E. ALLIE, MD

An Overview of Pharmacotherapy during Percutaneous Peripheral Interventions of Thrombotic Lesions
NICOLAS W. SHAMMAS, MD, MS, FACC


The Important Properties of Contrast Media: Focus on Viscosity

This special supplement was made possible through a grant from Guerbet LLC

RECENTLY ADDED

Anticoagulation Techniques for Peripheral Vascular Interventions

Archived Webcast





© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd., Suite 100, Malvern, PA 19355
Phone: 800.237.7285 610.560.0500 Fax: 610.560.0502
Privacy Policy